FAHD MOUSA: Open Payments
NPI 1588026124 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150,450 in 249 payments from 8 companies in 2025. Trend: 2023 $945 · 2024 $47,239 · 2025 $150,450
Honoraria: $74,525Speaker / faculty: $55,844Travel & lodging: $12,321Food & beverage: $7,760
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 137 | $86,148 |
| Otsuka America Pharmaceutical, Inc. | 77 | $40,590 |
| Teva Pharmaceuticals USA, Inc. | 26 | $22,864 |
| E.R. Squibb & Sons, L.L.C. | 3 | $345 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $256 |
| Janssen Pharmaceuticals, Inc | 1 | $113 |
| Lundbeck LLC | 2 | $92 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $42 |
Products named: Auvelity, UZEDY, ABILIFY MAINTENA, REXULTI, CAPLYTA, COBENFY, INVEGA SUSTENNA.
Industry payments across WV — which companies pay providers there.
